# FDA Inspection 1309914 - UC Reproductive Medicine at Kettering - March 23, 2026

Source: https://www.globalkeysolutions.net/records/fda_inspections/uc-reproductive-medicine-at-kettering/cde7fa29-fd70-46da-abce-e2b43f4ffc33
Source feed: FDA_Inspections

> FDA Inspection 1309914 for UC Reproductive Medicine at Kettering on March 23, 2026. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1309914
- Company Name: UC Reproductive Medicine at Kettering
- Inspection Date: 2026-03-23
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1309914 - 2026-03-23](https://www.globalkeysolutions.net/records/fda_inspections/uc-reproductive-medicine-at-kettering/4d0fb79f-f4cf-44f3-b676-a6ce190353ab)
- [FDA Inspection 1150253 - 2021-08-25](https://www.globalkeysolutions.net/records/fda_inspections/uc-reproductive-medicine-at-kettering/c886f357-18d1-49bd-b2ee-bd0a4567adc3)
- [FDA Inspection 1150253 - 2021-08-25](https://www.globalkeysolutions.net/records/fda_inspections/uc-reproductive-medicine-at-kettering/4e0a7ba3-0329-4bba-86d5-6f1bd52047d5)
- [FDA Inspection 1150253 - 2021-08-25](https://www.globalkeysolutions.net/records/fda_inspections/uc-reproductive-medicine-at-kettering/9537b9dd-266c-4b2b-ae2c-4b89d4342b1d)
- [FDA Inspection 1054286 - 2018-05-16](https://www.globalkeysolutions.net/records/fda_inspections/uc-reproductive-medicine-at-kettering/dc1ff2df-a37b-463e-a8db-4cf251a65e26)

Company: https://www.globalkeysolutions.net/companies/uc-reproductive-medicine-at-kettering/d3b8cdde-9422-4685-bb48-4e631ff63359

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d